Asthma is a chronic, lifelong condition without a cure that can cause life-threatening symptoms and affects 3.8 million Canadians.1–3 Although inhaled medication is the cornerstone of therapy, ...

(Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.TA) (TEVA.N) on Thursday launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline's (GSK.L) best-selling Advair.

“The FDA acceptance of these two filings represents an exciting time for Teva’s specialty respiratory medicines business as we integrate both fixed dose combination and monotherapy into our core, ...

The US Food and Drug Administration (FDA) has expanded the indication for the short-acting beta-agonist albuterol sulfate inhalation powder (ProAir RespiClick, Teva) to children aged 4 to 11 years, ...

(RTTNews) - Teva Canada, a unit of Teva Pharmaceutical Industries Ltd. (TEVA), announced Monday the product availability of Aermony RespiClick, a new device for the treatment of bronchial asthma. The ...

AirDuo RespiClick and ArmonAir RespiClick are expected to be available later this year. Teva announced that the Food and Drug Administration (FDA) has approved two new breath-activated, multi-dose dry ...

The US Food and Drug Administration (FDA) has approved the short-acting beta-agonist (SABA) albuterol sulfate inhalation powder (ProAir RespiClick, Teva) for the treatment or prevention of ...

Medically reviewed by Daniel More, MD Key Takeaways Asthma inhalers can be for quick relief or long-term control.Rescue ...

MONTRÉAL-- (BUSINESS WIRE)--Teva Canada, a subsidiary of Teva Pharmaceutical Industries Ltd., today announced product availability of Aermony RespiClick™, indicated for the maintenance treatment of ...

April 20 (Reuters) - Teva Pharmaceutical Industries Ltd on Thursday launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline's best-selling Advair. Teva, which won U.S.

Aermony RespiClick™ (fluticasone propionate inhalation powder), available in three dose options Asthma is a chronic, lifelong condition without a cure that can cause life-threatening symptoms and ...

A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. REUTERS/Ronen Zvulun By Divya Grover (Reuters) - Teva Pharmaceutical ...